Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 28 (2) , 111-124
- https://doi.org/10.1016/0010-7824(83)90011-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2Contraception, 1982
- Termination of early gestation with (15S)-15-methyl prostaglandin F2α methyl ester vaginal suppositoriesContraception, 1981
- Termination of early gestation with a single vaginal suppository of (15s)-15-methyl-prostaglandin F2α methyl esterContraception, 1980
- Termination of early gestation with a vaginal polysiloxane device impregnated with (15S) -15 methyl prostaglandin F2a methylesterProstaglandins, 1977
- Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2αContraception, 1975
- Intrauterine administration of prostaglandin F2α as an outpatient procedure for termination of early pregnancyContraception, 1974
- Termination of early pregnancy with prostaglandin E2 vaginal suppositoriesContraception, 1973
- Therapeutic abortion of early human gestation with vaginal suppositories of prostaglandin F2αAmerican Journal of Obstetrics and Gynecology, 1973
- Termination of early gestation with vaginal prostaglandin F2α tabletsProstaglandins, 1972
- Serum Luteinizing Hormone and Progesterone Concentration During the Menstrual Cycle of the Rhesus MonkeyJournal of Clinical Endocrinology & Metabolism, 1970